Leading the Way in Regenerative Medicine: QC Kinetix Revolutionizes Healthcare

Leading the Way in Regenerative Medicine: QC Kinetix Revolutionizes Healthcare

QC Kinetix is a fast-growing leader in regenerative medicine, offering patients cutting-edge, non-surgical solutions for joint and pain relief. Established in 2017, the company has rapidly gained prominence, now serving patients in over 100 cities nationwide and providing advanced non-surgical therapies to thousands.

QC Kinetix employs regenerative medicine techniques to activate the body’s natural healing processes, enhancing function and offering relief from musculoskeletal pain without the need for surgery.

In May 2024, QC Kinetix was honored as one of Entrepreneur’s top 10 New and Emerging Franchises for 2024. The magazine highlighted the company’s rise to No. 9, crediting its remarkable unit growth, financial strength, stability, and brand presence.

QC Kinetix achieved an exceptional 2,111% growth in units over the past three years, ranking it among the leading brands in the industry.

“We’re honored to rank among some of the fastest-growing franchise brands,” stated the CEO of QC Kinetix. “The recognition is a true testament to our entire team’s hard work and dedication. I’m excited to watch our brand continue to grow and push the boundaries of what’s possible in the regenerative medicine industry.”

QC Kinetix Supported by Leading Industry Experts

QC Kinetix is committed to offering patients an exceptional alternative for pain relief, focusing on helping people restore their quality of life without relying on pain medications, surgeries, or steroids. With its distinctive biologics treatment protocols, QC Kinetix has successfully treated thousands, underscoring its dedication to patient-centered care.

Recently, the company appointed renowned orthopedic surgeon Dr. Mitchell Sheinkop as its national medical director, further strengthening its medical leadership team.

Joining QC Kinetix marks a new chapter for Dr. Sheinkop, who brings over 37 years of expertise in joint replacement surgery. His decision to join the team highlights his belief in regenerative medicine’s potential to transform patient care.

As QC Kinetix’s national medical director, Dr. Sheinkop will lead the medical management team, concentrating on refining treatment protocols and driving research and development efforts to keep the franchise at the forefront of medical innovation. He also plans to integrate physical therapy and weight management into current treatments to further improve patient outcomes and satisfaction, strengthening the brand’s impact.

As QC Kinetix embarks on this exciting chapter with Dr. Sheinkop at the helm, his vast expertise—combining remarkable clinical accomplishments with a commitment to education and professional growth—makes him ideally suited to guide the company toward new heights of innovation and success.

The company also enjoys support from notable athletes, including Pro Football Hall of Famer Emmitt Smith, who represents QC Kinetix as its national spokesperson.

“I’ve got to keep taking care of these joints,” Smith shared, “no losing for this guy. When I take QC Kinetix natural supplements, it’s like – bam – Emmitt 2.0. Sometimes, you need a competitive edge.”

Learn About QC Kinetix

A medical doctor, a physician assistant, a nurse practitioner, and a business professional came together in one room.

Driven by a shared vision and ambition, they sought the perfect name for their new company. Wanting to honor their roots in Charlotte, North Carolina—fondly referred to as “the Queen City” (QC)—the first part of their company name was created.

The name “Kinetix” draws inspiration from kinetic energy, symbolizing movement. QC Kinetix’s mission is to help people regain mobility by using their own cells to stimulate regeneration.

The founders saw an opportunity to redefine conventional approaches to musculoskeletal pain management. They envisioned a modern, safer, and health-focused alternative, creating a concierge medical model centered around regenerative medicine to enhance patients’ quality of life. This dedication to pioneering solutions distinguishes QC Kinetix and fuels its ongoing advancements in the field of regenerative medicine.

Many patients experience pain that hinders them from fully enjoying activities such as golfing, climbing stairs, or playing with their grandchildren. QC Kinetix provides a superior treatment option that bypasses the need for harmful medications, toxic steroid injections, and the inherent risks of surgery.

“No longer did we want insurance to tell us what they were willing to pay to treat a patient,” a company spokesperson shared. “We wanted the research to tell us the most effective method, whether it was covered by insurance or not, and bring it to the United States in a very transparent and patient-focused manner. QC Kinetix is an opportunity to become the first option when dealing with pain, not the alternative to those ways. That is our mission over time.”

QC Kinetix: A Patient-Focused Approach to Regenerative Treatment

QC Kinetix, a pioneer in regenerative medicine, is dedicated to helping people stay active by providing comprehensive regenerative treatments for joint and musculoskeletal pain.

Through their specialized biologics protocols, they have successfully treated thousands of patients, supporting their mission to deliver effective, patient-centered care.

QC Kinetix leverages the body’s natural healing abilities through cutting-edge biological treatments, providing a non-invasive alternative to surgery and dependency on pain medications.

These clinics are devoted to enhancing the body’s innate capacity for self-repair, aiming to improve function and elevate overall quality of life from within.

Patients often seek QC Kinetix treatments for knee, shoulder, or hip pain, utilizing the body’s natural properties to promote healing and regeneration. Since its founding, the company has reached numerous milestones.

In 2023, QC Kinetix achieved over $100 million in system-wide sales, and by April 2024, the company celebrated serving its 40,000th patient since launching its nationwide expansion in 2021.

“It is our goal to change medicine,” shared the CEO of QC Kinetix. “We want to be the first thing people think about when they or a loved one are dealing with pain. We measure that success by seeing feedback from our patients that we could change their lives. We aim to care for our patients and employees first, knowing that growth and profit will follow.”

QC Kinetix Poised for Major Breakthrough

Having established a solid presence across the United States, QC Kinetix is now preparing for international growth. The company plans to expand into the United Kingdom, Australia, and New Zealand in the coming years, reinforcing its status as a global leader in regenerative medicine.

QC Kinetix also aims to reach 250 operational locations in the U.S. by the close of 2024.

That’s a substantial amount to achieve in just four years of franchising. Yet, the CEO of QC Kinetix expressed that the only surprise is that the company hasn’t grown even faster, given the high demand for alternatives to pain medications and surgeries. This impressive expansion underscores the strong consumer interest in non-surgical pain relief options and the keen interest of franchise investors in the medical field.

“I love this brand and our future,” said the CEO of QC Kinetix. “It’s about impacting people’s lives and being a game-changer in the medical field.”